|
|
|
|
LEADER |
02695nam a22003015i 4500 |
001 |
000281986 |
005 |
20210721081154.0 |
007 |
cr nn 008mamaa |
008 |
170831s2017 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319601748
|
024 |
7 |
|
|a 10.1007/978-3-319-60174-8
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a G-Protein-Coupled Receptor Dimers /
|c edited by Katharine Herrick-Davis, Graeme Milligan, Giuseppe Di Giovanni.
|
250 |
|
|
|a 1st ed. 2017.
|
260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Humana,
|c 2017.
|
300 |
|
|
|a XVII, 501 p. 70 illus., 58 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a The Receptors,
|v 33
|
505 |
0 |
|
|a Part I. Introduction -- 1. From Monomers to Dimers and Beyond: An Exciting Journey in the World of the G protein-coupled Receptor Family.- 2. The use of Spatial Intensity Distribution Analysis to Examine G protein-coupled Receptor Oligomerization -- 3. Advanced Microscopy Techniques for Studying G protein-coupled Receptors.- Part II. Receptors.- 4. Light Sensing G protein-coupled Receptor Rhodopsin Dimer -- 5. Extreme Vetting of Dopamine Receptor Oligomerization -- 6. Serotonin receptors.- 7. Cannabinoid and Opioid Receptor Heteromers -- 8. Di/oligomerization of Glycoprotein Hormone Receptors.- 9. Chemokine Receptor Oligomerization to Tweak Chemotactic Responses -- 10. Secretin Receptor Dimerization. Prototypic of Class B GPCR Behavior.- 11. Receptors and RAMPs -- 12. Obligatory Heterodimerization of GABAB Receptor.- 13. Metabotropic Glutamate Receptors. Part III. Assembly and Trafficking.- 14. The monomer/homodimer Equilibrium of G protein-coupled Receptors: Formation in the Secretory Pathway and Potential Functional Significance.- 15. Probing Self-assembly of G protein-coupled Receptor Oligomers in Membranes using Molecular Dynamics Modeling and Experimental Approaches.- 16. Interaction of Membrane Cholesterol with GPCRs: Implications in Receptor Oligomerization.- Part IV. Physiology and Therapeutic Potential.- 17. Allosterism within GPCR Oligomers: Back to Symmetry.- 18. Understanding the Physiological Significance of GPCR Dimers and Oligomers -- 19. Heteromers form Novel Signaling Complexes -- 20. Heteroreceptor Complexes Implicated in Parkinson’s Disease.
|
650 |
|
0 |
|a Neurosciences.
|
650 |
1 |
4 |
|a Neurosciences.
|
700 |
1 |
|
|a Herrick-Davis, Katharine.
|e editor.
|
700 |
1 |
|
|a Milligan, Graeme.
|e editor.
|
700 |
1 |
|
|a Di Giovanni, Giuseppe.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|